COVID-19

Views & Analysis

Coronavirus pharma news roundup – 24/07/20

With coronavirus vaccine trials finally showing positive results, analysts are starting to wonder what access challenges might lie ahead.

News

Influential MPs 'astonished' at UK government's delayed pand...

As the UK’s economy is hit by its worst contraction for 41 years, an influential committee of MPs has blasted the government’s failure to plan for the economic impact of a pandemic and stoc

News

Pandemic and currency headwinds hurt Roche in first half

Roche has announced half-year results showing the COVID-19 pandemic affected sales of its key products, with currency headwinds also weighing on revenues.

News

Controversy as pharma execs predict profits from COVID-19 va...

Concerns have emerged about access to some potential COVID-19 vaccines after pharma executives from three companies said they expect to make profits from their products in evidence to a US

Views & Analysis

MSD’s David Peacock on moving UK healthcare forward

David Peacock has worked across the world for MSD and other companies, and has now taken the helm of MSD’s UK & Ireland operations.

News

Healthware's New Normal resource hub for COVID-19

Healthware launches global resource hub for COVID-19’s 'new ...

Healthware has launched a new online resource that aggregates information and analysis on how to respond to the huge changes COVID-19 has wrought across life sciences and healthcare.

Coronavirus pharma news roundup – 24/07/20

Influential MPs 'astonished' at UK government's delayed pand...

Pandemic and currency headwinds hurt Roche in first half

Controversy as pharma execs predict profits from COVID-19 va...

MSD’s David Peacock on moving UK healthcare forward

Healthware launches global resource hub for COVID-19’s 'new ...

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks